U.S. approves first marijuana plant-derived drug for epilepsy

(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc's epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.

from Reuters: U.S. https://ift.tt/2KkSA9O